Simple preoperative parameters to assess technical difficulty during a radical perineal prostatectomy - Abstract

PURPOSE: We aimed to propose a practical selection method predicting the easier radical perineal prostatectomy (RPP) cases before the operation.

METHODS: Fifty sequential RPP cases were divided into two groups according to the estimated difficulty of the operation (Group I: Easier, Group II: Difficult) which was assessed by using a RPP difficulty scale, constituted by three parameters (operation time, blood loss, and the judgment of the surgeon) each ranging between 1 and 3 points. As the localization parameters, skin-to-prostatic apex (SPAD) and skin-to-prostatic base (SPBD) distances and distance between bilateral ischial tuberosities (ITD) were measured. During suprapubic ultrasonography, a probe-divergence angle (PDA) and prostate volumes (PV) were recorded. These parameters were compared between the groups.

RESULTS: In Group I (n = 29) and Group II (n = 21), the difficulty scores were 4.37 (3-5) and 6.80 (6-9), respectively. Data of age, clinical stages, and findings of digital rectal examination were not different between groups. While SPBD, SPAD, and ITD values were found similar (p > 0.05), PDA and PV were significantly different. PDA was > 45 degree in 21 cases in Group I (72.4 %) and in 7 cases in Group II (33.3 %) (p = 0.011). The mean of PV was 37.4 (20-60) cc and 49.9 (30-75) cc in Group I and Group II, respectively (p = 0.001).

CONCLUSIONS: While planning RPP operations, by selecting the prostate cancer cases with a prostate of low volume and localized deeper in the pelvis during suprapubic ultrasonography, urologists may have a chance to perform this technique more easily during the learning period.

Written by:
Horuz R, Göktaş C, Cetinel CA, Akça O, Cangüven O, Sahin C, Kafkaslı A, Albayrak S.   Are you the author?
Kartal Egitim Arastırma Hastanesi, Uroloji Kliniği, Ana Bina, Kat 9, Cevizli, Kartal, Istanbul, Turkey.

Reference: Int Urol Nephrol. 2012 Oct 7. Epub ahead of print.


PubMed Abstract
PMID: 23054325

UroToday.com Prostate Cancer Section